Product Information
ALENDRONATE SODIUM 35 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2813 per EA under NDC 64980034114. Its NADAC has been published 371 times since Aug 28, 2019.
FDA first approved this application on Aug 4, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
35 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980034114
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALENDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090124FDA Approved
8/4/2008
TE Code
AB
On Market Since
8/4/2008
Pharmacological Classes
Price Statistics
The NADAC for ALENDRONATE SODIUM 35 MG TAB has been published 371 times since Aug 28, 2019, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2813 per EA |
|---|---|
| All-time high | $0.4690 (Sep 11, 2019) |
| All-time low | $0.2813 (Sep 23, 2026) |
| 52-week high | $0.3120 |
| 52-week low | $0.2813 |
| Median price | $0.3556 |
| Average price | $0.3612 |
| Largest weekly change | -17.6% (Jul 22, 2020) |
| Weeks tracked | 371 |
| Tracking since | Aug 28, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alendronate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALENDRONATE SODIUM 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALENDRONATE SODIUM 35 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.2813 per EA (NDC 64980034114), effective Sep 30, 2026.
How has the price of ALENDRONATE SODIUM 35 MG TAB changed over time?
Over the history we have for it, the NADAC for ALENDRONATE SODIUM 35 MG TAB has declined 40.0%. It has been tracked across 371 weekly CMS publications since Aug 28, 2019.
What are the highest and lowest recorded NADAC prices for ALENDRONATE SODIUM 35 MG TAB?
Since Aug 28, 2019, the NADAC for ALENDRONATE SODIUM 35 MG TAB has ranged from a low of $0.2813 (Sep 23, 2026) to a high of $0.4690 (Sep 11, 2019), with a median of $0.3556 per EA.
Are there cheaper alternatives to ALENDRONATE SODIUM 35 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALENDRONATE SODIUM 35 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ALENDRONATE SODIUM 35 MG TAB?
ALENDRONATE SODIUM 35 MG TAB (NDC 64980034114) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.